Article
Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity
2021-05-28
Abstract excerpt
The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 is a major global public threat. Currently, a worldwide effort has been mounted to generate billions of effective SARS-CoV-2 vaccine doses to immunize the world’s population at record speeds. However, there is still demand for alternative effective vaccines that rapidly confer long-term protection and rely upon cost-effective, easily scaled-up manufacturin...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced biosensing and bioanalysis techniques
- Animal Virus Infections Studies
- Bacteriophages and microbial interactions
- Immunotherapy and Immune Responses
- Respiratory viral infections research
- SARS-CoV-2 and COVID-19 Research
- vaccines and immunoinformatics approaches
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- 28b25a73-f045-515c-85c5-5e8d804c35b3
- DOI
- 10.1101/2021.05.28.446009
